Source: Υπουργείο Υγείας (CY) Revision Year: 2023 Publisher: CRESCENT PHARMA INTERNATIONAL LIMITED, 260, Triq San Albert, Gzira GZR 1150, Malta, Tel: (01256) 772730, Fax: (01256) 772740
CODANOL 500 mg/20 mg tablets.
| Pharmaceutical Form |
|---|
|
CODANOL tablets are white to off-white, circular, flat-faced tablets with a beveled edge, engraved PD/20 on one side. |
CODANOL tablets contain Paracetamol 500 mg and Dihydrocodeine Tartrate 20 mg.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Dihydrocodeine |
Dihydrocodeine is a semisynthetic narcotic analgesic with a potency between morphine and codeine. It is also a centrally-acting anti-tussive. Dihydrocodeine works on the cough centre to lessen the incidence and intensity of coughing fits. |
|
| Paracetamol |
Paracetamol is a medication used to treat pain and fever. It does appear to selectively inhibit COX activities in the brain, which may contribute to its ability to treat fever and pain. |
| List of Excipients |
|---|
|
CODANOL tablets contain: Magnesium stearate |
CODANOL tablets are disposed in PVdC/PVC blister pack 20μm hard tempered aluminium backing foil (10 tablets) in a printed carton. Each printed carton contains 20 tablets (2 blisters of 10).
CRESCENT PHARMA INTERNATIONAL LIMITED, 260, Triq San Albert, Gzira GZR 1150, Malta, Tel: (01256) 772730, Fax: (01256) 772740
19859
Date of first authorization: 28th December 2005
| Drug | Countries | |
|---|---|---|
| CODANOL | Cyprus |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
